Lyphochek Assayed Chemistry Control

Levels 1 and 2
C-310-5 Level 1 12 x 5 mL Level 1 26411
C-315-5 Level 2 12 x 5 mL 0459 2019-01-31 26410 Level 2 26412
313X MiniPak 2 x 5 mL

http://www.myeinserts.com/26410

INSTRUMENT (1)
Level 1 - 26411 Level 2 - 26412
Units Mean Range Mean Range
SIEMENS ADVIA CHEMISTRY SYSTEMS
Acetaminophen (Enzymatic) (ACET) g/mL 12.3 9.77 14.8 81.5 66.7 96.3
Albumin (Bromcresol Green (BCG)) (ALB, ALB_c) g/dL 3.74 3.50 3.98 2.44 2.25 2.62
Albumin (Bromcresol Purple (BCP)) (ALBP) g/dL 3.72 3.42 4.01 2.45 2.18 2.72
Alkaline Phosphatase (PNPP, AMP Buffer) (ALPAMP, ALPA_c) (2) U/L 113 90.2 136 416 358 473
Alkaline Phosphatase (PNPP, AMP Buffer) (IFCC) (ALP_2c) (2) (4) U/L 97.0 82.0 111 350 298 403
Alkaline Phosphatase (PNPP, DEA Buffer) (ALPDEA) (2) (4) U/L 159 135 183 504 429 580
Alpha-HBDH (Greiner) (2) U/L 160 136 184 393 346 441
ALT/SGPT (UV with P5P) (ALTP5P, ALTP_c) (2) U/L 33.6 27.2 40.0 98.1 87.8 108
ALT/SGPT (UV without P5P) (ALT, ALT_c) (2) U/L 33.8 27.0 40.6 99.5 88.5 111
Amylase (Ethylidene blocked-pNPG7) (AMYLAS) (2) U/L 75.7 66.7 84.6 376 329 423
Amylase (Pancreatic) (Antibody-blocked colorimetric analysis) (2) U/L 46.5 41.0 51.9 356 327 386
AST/SGOT (UV with P5P) (ASTP5P, ASTP_c) (2) U/L 41.9 33.2 50.7 211 190 232
AST/SGOT (UV without P5P) (AST, AST_c) (2) U/L 44.1 36.3 51.9 198 178 219
Bilirubin, Direct (Vanadate Oxidation) (DBIl_2), restand. mg/dL 0.295 0.224 0.366 1.42 1.12 1.72
Bilirubin (Direct) (Vanadate Oxidation) (DBIL_2) mg/dL 0.407 0.309 0.505 1.91 1.51 2.31
Bilirubin (Total) (Vanadate Oxidation) (TBIL_2) mg/dL 1.11 0.930 1.29 4.09 3.48 4.70
Calcium (Arsenazo III) (CA_2, CA_2c) mg/dL 9.30 8.58 10.0 11.8 11.0 12.6
Calcium (o-cresolphthalein complexone) (CA, CA_c) mg/dL 9.25 8.55 9.96 12.3 11.4 13.2
Carbamazepine (EIA) (CARB_2) g/mL 3.05 2.26 3.84 16.0 11.5 20.6
Carbon Dioxide (CO2) (Enzymatic) (CO2_L, CO2_c) mEq/L 36.9 27.5 >40.0 21.8 16.3 27.3
Chloride (ISE indirect) (CL) mEq/L 105 99.1 111 86.7 81.8 91.6
Cholesterol (HDL) (Direct measure) (DHDL) (7) mg/dL 54.7 43.8 65.6 17.8 15.0 20.6
Cholesterol (LDL) (Direct measure) (DLDL) mg/dL 130 105 155 48.0 39.0 57.0
Cholesterol (Total) (Cholesterol oxidase, esterase, peroxidase) (CHOL_2, CHOL_c) mg/dL 249 222 276 105 96.8 113
Cholinesterase (Butyrylthiocholine (Trinder)) (CHE) (2) U/L 6525 5800 7251 <1500
Creatine Kinase (CK) (NAC activated) (CKNAC) (2) U/L 131 114 148 422 380 465
Creatine Kinase (CK) (NAC activated) (IFCC 2002) (CKNAC) (2) U/L 134 118 150 427 380 474
Creatinine (Enzymatic) (ECRE_2) mg/dL 1.69 1.49 1.89 4.85 4.41 5.29
Creatinine (Jaffe) (CREA, CREA_2, CRE_2c) mg/dL 2.41 2.05 2.76 5.33 4.90 5.76
Digoxin (Immunoturbidimetric) (DIG) ng/mL 0.956 0.559 1.35 3.23 2.91 3.55
Gamma Glutamyltransferase (GGT) (IFCC 2002) (2) U/L 59.0 42.9 75.0 150 118 182
Gentamicin (EIA) (GENT_2) g/mL 1.52 1.15 1.88 5.69 5.19 6.18
Glucose (GLUO, GLUO_2) mg/dL 80.2 70.4 90.0 258 234 283
Glucose (Hexokinase) (GLUH, GLUH_3, GLUH_c) mg/dL 80.2 69.8 90.5 266 245 288
Immunoglobulin A (IgA) (Immunoturbidimetric) (IGA_2) mg/dL 221 156 286 142 105 178
Immunoglobulin G (IgG) (Immunoturbidimetric) (IGG_2) mg/dL 918 818 1017 603 542 663
Immunoglobulin M (IgM) (Immunoturbidimetric) (IGM_2) mg/dL 81.8 69.5 94.0 55.2 44.2 66.1

Page 1 English 2016-02 4030-00

8
 Lyphochek Assayed Chemistry Control, Levels 1 and 2

INSTRUMENT (1)
Level 1 - 26411 Level 2 - 26412
Units Mean Range Mean Range
SIEMENS ADVIA CHEMISTRY SYSTEMS (continued)
Iron (Ferrozine-no deproteinization) (IRON_2) g/dL 230 212 248 61.7 53.9 69.4
Iron (TIBC) (Ferric chloride, alumina) (TIBC) g/dL 332 297 368 233 205 261
Lactate (Lactic Acid) (Lactate to pyruvate) (LAC) mg/dL 43.4 38.2 48.6 12.6 11.3 13.9
Lactate Dehydrogenase (LDH) (Lactate/NAD) (IFCC 2002) (LDLP) (2) U/L 175 156 194 373 333 413
Lactate Dehydrogenase (LDH) (Pyruvate/NADH) (LDPL) (2) U/L 334 262 405 777 655 900
Lipase (Enzymatic, colorimetric) (LIP) (2) U/L 47.4 37.7 57.1 80.1 66.5 93.7
Lithium (Colorimetric) (LITH) mEq/L 0.560 0.434 0.687 1.81 1.59 2.04
Magnesium (Xylidyl blue) (MG, MG_c) mg/dL 2.13 1.84 2.41 4.30 3.79 4.81
Phenobarbital (EIA) (PHNB_2) g/mL 13.0 7.50 18.4 46.2 34.2 58.2
Phenytoin (EIA) (PHYN_2) g/mL 11.8 8.35 15.3 22.6 15.5 29.8
Phosphorus (Phosphomolybdate method) (IP, IP_c) mg/dL 3.77 3.31 4.22 7.21 6.70 7.73
Potassium (ISE indirect) (K) mEq/L 3.98 3.72 4.24 6.14 5.82 6.46
Protein Serum (Total) (Biuret, no serum blank, end point) (TP, TP_c) g/dL 6.23 5.82 6.65 4.08 3.75 4.41
Salicylate (Enzymatic) (SAL) mg/dL 5.52 3.59 7.45 16.1 14.2 18.0
Sodium (ISE indirect) (NA) mEq/L 147 141 154 129 124 134
Theophylline (EIA) (THEO_2) g/mL 8.78 6.94 10.6 22.4 17.6 27.3
Tobramycin (EIA) (TOB_2) g/mL 6.74 5.74 7.75 1.51 1.12 1.90
Transferrin (Immunoturbidimetric) (TRF) mg/dL 260 228 291 177 155 199
Triglycerides (Enzymatic, end point) (TRIG) mg/dL 196 175 217 95.4 84.9 106
Urea Nitrogen (BUN) (Urease, UV) (UN, UN_c) (5) mg/dL 16.1 14.1 18.1 46.5 42.3 50.6
Uric Acid (Uricase, colorimetric) (UA, UA_c) mg/dL 4.98 4.50 5.45 10.0 9.44 10.6
Valproic Acid (EIA) (VPA_2) g/mL 36.8 27.1 46.6 110 98.8 122
Vancomycin (EIA) (VANC_2) g/mL 7.48 5.99 8.98 29.6 23.1 36.2

FOOTNOTES
(1) All footnotes may not apply to your custom selected data chart.
(2) Values were obtained at 37C.
(3) The mean value is calculated from data generated by instruments using this method.
(4) The assigned values were determined using the reagent and/or instrument manufacturers protocol and may not represent 3SD ranges.
(5) mg/dL Urea Nitrogen x 2.14 = mg/dL Urea. S.I. Units value range is expressed as Urea.
(6) This product has been tested using the methodologies listed in the package insert. The performance of this product has not been evaluated for use with
capillary electrophoresis methods.
(7) Direct methods only.
(8) % Total Protein
Data is not available at this time. Please inquire.
The data required to establish the means and acceptable ranges for this assay were not obtained due to limited assignment participation. If your facility is
interested in participating in the Value Assignment Program for this assay, please contact your local Bio-Rad office.

Page 2 English 2016-02 4030-00